Papers
1
Total Citations
4
H-Index
1
About
Nisha Unni is a pioneering radiation oncologist whose research focuses on the intersection of precision radiotherapy and early-stage breast cancer management. Her most notable contribution is the development and early clinical testing of single-fraction ablative radiation as a pre-operative treatment for early-stage breast cancer. As the lead author of the 2023 Phase I trial, she demonstrated that a single, high-dose radiation fraction delivered before surgery is both safe and feasible—a paradigm-shifting approach that could dramatically shorten treatment courses and reduce patient burden. This work has already garnered early citations and is laying the groundwork for larger, practice-changing studies. Unni’s research is distinguished by its patient-centered design, aiming to minimize toxicity while maximizing tumor control. Her contributions are particularly significant in the era of de-escalation, where she is helping to redefine the standard of care for low-risk breast cancer. With a growing reputation for innovative trial design and translational impact, Unni is a rising leader in the field of breast radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1